Skip to main content
. 2014 Nov 19;18(6):508. doi: 10.1186/s13054-014-0508-y

Table 14.

Genes downregulated between six- and eightfold in peripheral blood mononuclear cells of patients with stable COPD or AECOPD compared to healthy control subjects a

Stable vs Con AE-1 vs Con AE-3 vs Con AE-10 vs Con
Fold changes Genes Fold changes Genes Fold changes Genes Fold changes Genes
6.0 NDUFV3 6.0 MAL 6.0 IL7R 6.0 HKDC1
6.0 C17orf45 6.0 ARHGAP12 6.0 CD28 6.1 TANC2
6.1 MAL 6.0 TRAPPC4 6.0 KIR2DS1 6.1 FAM5B
6.1 CXCR6 6.0 GNLY 6.0 FLJ20647 6.2 KIAA0748
6.1 SUCLA2 6.0 N/A 6.1 N/A 6.3 CD40LG
6.1 C21orf7 6.0 LOC642376 6.1 CLDN1 6.3 PCDH10
6.2 TNPO1 6.0 MYOZ3 6.1 TRBV5-4 6.3 LOC644273
6.2 LOC643514 6.1 FLJ20647 6.1 CARD11 6.3 CD96
6.2 ALS2CR13 6.1 CD96 6.1 LOC441320 6.3 TRA@
6.2 CREB1 6.2 MAL 6.1 ACADSB 6.3 TRBV3-1
6.2 C17orf45 6.2 GIMAP5 6.1 NXPH4 6.4 TRA@
6.3 NELL2 6.2 CLDN1 6.2 SCNN1D 6.4 LOC642483
6.3 C6orf32 6.2 CD3D 6.2 MTMR1 6.5 ANKDD1A
6.3 LOC642455 6.2 LY9 6.2 MAL 6.5 N/A
6.4 GMDS 6.3 LOC123876 6.2 ZAP70 6.5 N/A
6.4 ABHD6 6.3 TNFRSF25 6.3 MAL 6.5 LY9
6.4 DAPP1 6.3 C21orf7 6.3 IL2RB 6.6 CD8B
6.4 SH3BGRL 6.3 LOC645885 6.3 EDG8 6.6 MGC26597
6.5 IL7R 6.3 BLOC1S3 6.3 HKDC1 6.7 TRBV19
6.6 LOC441601 6.3 LOC644727 6.3 SCAP1 6.7 LOC145783
6.6 GPR18 6.4 CCDC45 6.3 LOC440455 6.8 CD8B
6.7 P2RX5 6.4 C21orf7 6.3 CD300E 6.9 C21orf7
6.7 LY9 6.5 CD28 6.4 LY9 6.9 UBASH3A
6.8 GGPS1 6.5 LOC440455 6.4 KIR2DS2 7.0 LOC400768
6.8 EIF3S6 6.5 IL24 6.4 SLAMF6 7.1 CD8B
6.8 ARHGAP15 6.5 GHRL 6.4 SAA3P 7.1 HAND1
6.8 SF3B1 6.5 FAM113B 6.4 SF3A2 7.2 LOC126075
6.8 GPR89A 6.5 LOC644663 6.5 UNQ470 7.2 TNFRSF7
6.9 LOC129293 6.5 C15orf37 6.5 C6orf21 7.3 LEF1
6.9 CPNE3 6.5 MAL 6.6 CD96 7.3 HLA-DOA
6.9 LY9 6.5 LOC644445 6.6 CD244 7.4 LOC646279
7.0 PIP3-E 6.6 LOC126075 6.6 N/A 7.4 YLPM1
7.0 TAF9 6.6 1-Sep 6.6 KLRK1 7.4 LOC643514
7.0 N/A 6.6 UBASH3A 6.6 C16orf5 7.5 MTMR1
7.0 KIAA0748 6.7 SAA3P 6.6 TRBC1 7.6 NOG
7.1 CD55 6.8 CD6 6.6 LOC339778 7.7 TCF7
7.2 EIF3S6 6.8 TRBV5-4 6.7 GNLY 7.7 KIAA0748
7.2 PGRMC2 6.9 1-Sep 6.7 LDLRAP1 7.7 C21orf7
7.3 C21orf7 6.9 LOC129293 6.8 HAND1 7.7 PRDM9
7.4 PSMD6 7.0 SCNN1D 6.8 CD3D 7.7 FCER2
7.5 ABLIM1 7.0 SIT1 6.8 FLJ45825 7.9 CD8B
7.6 STAG2 7.1 GATA3 6.8 SF3A2 8.0 LEF1
7.8 CCDC45 7.1 CD7 6.8 CXCR3
7.8 UNQ470 7.1 CDKN3 6.8 KIR3DL3
7.9 LY9 7.2 SCAP1 6.8 LAT
8.0 CD40LG 7.3 TRA@ 6.9 CD52
7.3 LY9 6.9 TNFRSF7
7.3 DDAH1 6.9 LOC442726
7.3 TRA@ 6.9 3-Sep
7.5 TNFRSF7 6.9 KIAA0748
7.5 KIAA0748 6.9 XG
7.6 ITM2A 6.9 KIAA1549
7.6 CD5 7.0 RNF157
7.6 D4S234E 7.0 SIT1
7.6 CD300E 7.0 CD1C
7.7 APBB1 7.0 SLC16A10
7.8 CD3D 7.0 CD3G
7.8 LCK 7.1 CD6
7.8 UBASH3A 7.1 LY9
7.9 XG 7.1 FLT3LG
7.1 LOC647353
7.2 LOC123876
7.2 CX3CR1
7.2 LOC126075
7.3 NELL2
7.4 LY9
7.4 MAL
7.4 KIR2DS2
7.4 CHIA
7.4 BIN1
7.5 CCDC78
7.5 MAL
7.5 C21orf7
7.5 KIR2DL4
7.6 CD6
7.6 CD3D
7.7 1-Sep
7.7 LCK
7.8 ITM2A
7.8 TRA@
7.9 SIT1
7.9 CD5
8.0 CD8A
8.0 LOC129293

aData are from patients with stable chronic obstructive pulmonary disease (Stable) or acute exacerbation of chronic obstructive pulmonary disease on day 1 (AE-1), day 3 (AE-3) and day 10 (AE-10) after the hospital admission, as compared to healthy controls (Con).